EUS followed by EMR for staging of high-grade dysplasia and early cancer in Barrett's esophagus

被引:164
作者
Larghi, A
Lightdale, CJ
Memeo, L
Bhagat, G
Okpara, N
Rotterdam, H
机构
[1] Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA
[2] Columbia Univ Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA
关键词
D O I
10.1016/S0016-5107(05)00319-6
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Accurate staging of high-grade dysplasia and of early cancer in Barrett's esophagus is important in the selection of patients for endoscopic therapy. Methods: Patients with Barrett's esophagus and biopsy specimen proven high-grade dysplasia and adenocarcinoma in focal nodular lesions or in endoscopically unapparent flat lesions in short-segment Barrett's esophagus were initially staged with EUS. In patients with disease limited to the mucosa on EUS, cap-assisted EMR was performed. The depth of tumor invasion on EMR specimens was classified in a similar manner to squamous-cell cancer of the esophagus: nil (epithelial layer, dysplasia), m2 (lamina propria invasion), m3 (muscularis mucosae invasion), sm (submucosal invasion). Results: EUS was performed in 48 consecutive patients (27 with focal nodular lesions and 21 with microscopic lesions), and submucosal invasion was diagnosed in 8 (confirmed in 7/8 at surgery). EMR was carried out in the remaining 40 patients without significant complications. In the 25 patients with high-grade dysplasia on prior biopsy specimens, EMR confirmed m1 disease in 19; whereas in 6 (24%), invasive adenocarcinoma was detected (to m2 in 4; to m3 in 2). In the 15 patients with invasive cancer on prior biopsy specimens and staged as intramucosal cancer on EUS, intramucosal carcinoma was confirmed in 9 (m2 in 3; m3 in 6); whereas, in 6 patients (40%), submucosal invasion was found. Overall, EUS provided accurate staging in 41/48 patients (85%) with one patient overstaged and 6 patients understaged compared with pathologic staging obtained by surgery or EMR. Of the 34 patients with m1 to m3 staging after EMR, 29 were treated endoscopically and had no evidence of cancer after a mean follow-up of 22.9 months(standard deviation 9.2 months). Conclusions: EMR provides pathologic staging information that, in addition, may be helpful after EUS if a stage-determined approach is used in the management of high-grade dysplasia and of early cancer in Barrett's esophagus. EMR may he particularly useful for staging of focal nodules or in short-segment Barrett's esophagus with microscopic lesions when endoscopic therapy is an option.
引用
收藏
页码:16 / 23
页数:8
相关论文
共 36 条
[1]   Hospital volume and surgical mortality in the United States. [J].
Birkmeyer, JD ;
Siewers, AE ;
Finlayson, EVA ;
Stukel, TA ;
Lucas, FL ;
Batista, I ;
Welch, HG ;
Wennberg, DE .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (15) :1128-1137
[2]   Combined endoscopic mucosal resection and photodynamic therapy for esophageal neoplasia within Barrett's esophagus [J].
Buttar, NS ;
Wang, KK ;
Lutzke, LS ;
Krishnadath, KK ;
Anderson, MA .
GASTROINTESTINAL ENDOSCOPY, 2001, 54 (06) :682-688
[3]   Clinical applications of a new through-the-scope ultrasound probe: Prospective comparison with an ultrasound endoscope [J].
Chak, A ;
Canto, M ;
Stevens, PD ;
Lightdale, CJ ;
VandeMierop, F ;
Cooper, G ;
Pollack, BJ ;
Sivak, MV .
GASTROINTESTINAL ENDOSCOPY, 1997, 45 (03) :291-295
[4]   Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett's esophagus [J].
Ell, C ;
May, A ;
Gossner, L ;
Pech, O ;
Günter, E ;
Mayer, G ;
Henrich, R ;
Vieth, M ;
Müller, H ;
Seitz, G ;
Stolte, M .
GASTROENTEROLOGY, 2000, 118 (04) :670-677
[5]   Medical progress - Esophageal cancer [J].
Enzinger, PC ;
Mayer, RJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (23) :2241-2252
[6]   Barrett's esophagus with high-grade dysplasia - An indication for prophylactic esophagectomy [J].
Heitmiller, RF ;
Redmond, M ;
Hamilton, SR .
ANNALS OF SURGERY, 1996, 224 (01) :66-71
[7]  
Holscher A H, 1997, Dis Esophagus, V10, P179
[8]   Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus [J].
Hulscher, JBF ;
van Sandick, JW ;
de Boer, AGEM ;
Wijnhoven, BPL ;
Tijssen, JGP ;
Fockens, P ;
Stalmeier, PFM ;
ten Kate, FJW ;
van Dekken, H ;
Obertop, H ;
Tilanus, HW ;
van Lanschot, JJB .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (21) :1662-1669
[9]   ENDOSCOPIC MUCOSAL RESECTION WITH A CAP-FITTED PANENDOSCOPE FOR ESOPHAGUS, STOMACH, AND COLON MUCOSAL LESIONS [J].
INOUE, H ;
TAKESHITA, K ;
HORI, H ;
MURAOKA, Y ;
YONESHIMA, H ;
ENDO, M .
GASTROINTESTINAL ENDOSCOPY, 1993, 39 (01) :58-62
[10]   The role of endoscopy in the assessment and treatment of esophageal cancer [J].
Jacobson, BC ;
Hirota, W ;
Baron, TH ;
Leighton, JA ;
Faigel, DO .
GASTROINTESTINAL ENDOSCOPY, 2003, 57 (07) :817-822